It is important to note that the Administrations continued response to COVID-19 is not fully dependent on the COVID-19 PHE, and there are significant flexibilities and actions that will not be affected as we transition from the current phase of our response. Testing is recommended immediately (but not earlier than 24 hours after the exposure) and, if negative, again 48 hours after the first negative test and, if negative, again 48 hours after the second negative test. Recommended infection prevention and control (IPC) practices when caring for a patient with suspected or confirmed SARS-CoV-2 infection, high levels of vaccine-and infection-induced immunity and the availability of effective treatments and prevention tools, higher-riskexposure (for healthcare personnel (HCP), Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2, Policy & Memos to States and Regions | CMS, barrier face covering that meets ASTM F3502-21 requirements including Workplace Performance and Workplace Performance Plus masks. Once the patient has been discharged or transferred, HCP, including environmental services personnel, should refrain from entering the vacated room without all recommended PPE until sufficient time has elapsed for enough air changes to remove potentially infectious particles [more information (to include important footnotes on its application) on. As a result of this and other efforts, since the peak of the Omicron surge at the end of January 2022: We have come to this point in our fight against the virus because of our historic investments and our efforts to mitigate its worst impacts. 497 0 obj
<>stream
If this responsibility is assigned to EVS personnel, they should wear all recommended PPEwhen in the room. They are not personal protective equipment (PPE) appropriate for use by healthcare personnel. Further information about source control options is available at: Masks and Respirators (cdc.gov). These policies allowed for audio-only modalities to initiate buprenorphine prescribing. CDCs guidance to use NIOSH-approved particulate respirators with N95 filters or higher when providing care for patients with suspected or confirmed SARS-CoV-2 infection is basedon the current understanding of SARS-CoV-2 and related respiratory viruses.